Abbott Laboratories (ABT) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abbott Laboratories.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:01.873 Good morning and thank you for standing by. 00:00:01.873 -- 00:00:07.638 Welcome to Abbott's first quarter 2025 earnings conference call. 00:00:07.638 -- 00:00:11.261 All participants will be able to listen only until the question and answer portion of 00:00:11.261 -- 00:00:16.966 this call. During the question and answer session, you will be able to ask your question 00:00:16.966 -- 00:00:21.270 by pressing the star one one keys on your touchtone phone. 00:00:21.270 -- 00:00:26.415 This call is being recorded by Abbott. With the exception of any participants questions 00:00:26.415 -- 00:00:31.235 asked during the question and answer session, the entire call including the question 00:00:31.235 -- 00:00:35.040 and answer session, is material copyrighted by Abbott. 00:00:35.040 -- 00:00:40.227 It cannot be recorded or rebroadcast without Abbott's express written permission. 00:00:40.227 -- 00:00:46.172 I would now like to introduce Mr. Mike Camilla, Vice President, Investor Relations. 00:00:46.495 -- 00:00:48.978 Good morning, everyone, and thank you for joining us. 00:00:48.978 -- 00:00:54.465 With me today are Robert Ford, Chairman and Chief Executive Officer, and Phil Boudreau, 00:00:54.465 -- 00:00:59.161 Executive Vice President, Finance, and Chief Financial Officer. 00:00:59.161 -- 00:01:01.945 Robert and Phil will provide opening remarks. 00:01:01.945 -- 00:01:05.410 Following their comments, we'll take your questions. 00:01:05.410 -- 00:01:09.816 Before we get started, some statements made today may be forward looking for purposes 00:01:09.816 -- 00:01:15.043 of the Private Securities Litigation Reform Act of 1995, including 00:01:15.043 -- 00:01:18.946 the expected financial results for 2025. 00:01:19.394 -- 00:01:24.400 Abb...